Supporting this, in a recent study investigating incident cancer and cancer-related mortality, using raised alanine aminotransferase levels as a surrogate marker for NAFLD in three independent Scottish cohorts, it was shown that FLI predicted risk of mortality from cancer.39 The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.